the Effect of Implanon on Menstrual Patterns
1 other identifier
observational
200
0 countries
N/A
Brief Summary
This study aims to evaluate whether the timing of postpartum Implanon insertion (immediately postpartum, early postpartum, or late postpartum) affects menstrual patterns
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 13, 2025
CompletedFirst Posted
Study publicly available on registry
April 20, 2025
CompletedStudy Start
First participant enrolled
May 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
ExpectedApril 23, 2025
April 1, 2025
1 year
April 13, 2025
April 18, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
The Effect of Implanon on Menstrual Patterns According to Timing of Insertion After Delivery
To compare the effect of Implanon insertion at different postpartum intervals (immediate, early, late) on menstrual cycle patterns * To assess the prevalence of irregular bleeding, amenorrhea, and prolonged bleeding across different insertion groups. * To analyze general trends in menstrual changes, regardless of insertion timing.
baseline
Interventions
implanon is a long acting ,reversible contraceptive implants used to prevent pregnancy
Eligibility Criteria
Women will be grouped into: 1. Immediate postpartum (Insertion within 48 hours of delivery). 2. Early postpartum (Insertion between 4-6 weeks postpartum). 3. Late postpartum (Insertion after 6 weeks postpartum
You may qualify if:
- Postpartum women opting for Implanon as contraception.
- No contraindications to hormonal contraception.
You may not qualify if:
- Women with known bleeding disorders.
- Use of other hormonal contraceptives during the study period.
- Postpartum complications such as severe infections or retained products of conception
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (4)
Mazza D, Harrison C, Taft A, Brijnath B, Britt H, Hobbs M, Stewart K, Hussainy S. Current contraceptive management in Australian general practice: an analysis of BEACH data. Med J Aust. 2012 Jul 16;197(2):110-4. doi: 10.5694/mja11.11599.
PMID: 22794058BACKGROUNDRichters J, Grulich AE, de Visser RO, Smith AM, Rissel CE. Sex in Australia: contraceptive practices among a representative sample of women. Aust N Z J Public Health. 2003;27(2):210-6. doi: 10.1111/j.1467-842x.2003.tb00810.x.
PMID: 14696713BACKGROUND. Product information: Implanon NXT, Schering-Plough Pty Ltd, 12 November 2010
BACKGROUNDProduct information: Implanon® Implant, Organon (Australia) Pty Ltd, 19 March 2008.
BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
AHMED MOHAMED ABBAS, PROF.DR
Assiut University
- STUDY CHAIR
MOHAMED SAYED ABDELLAH, PROF.DR
Assiut University
- STUDY CHAIR
ALAA AHMED MAKHLOUF, DR
Assiut University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- OBSTETRICS AND GYNECOLOGY RESIDENT
Study Record Dates
First Submitted
April 13, 2025
First Posted
April 20, 2025
Study Start
May 1, 2025
Primary Completion
May 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
April 23, 2025
Record last verified: 2025-04